- Report
- May 2022
- 330 Pages
Global
From €2659EUR$3,000USD£2,289GBP
- Report
- May 2022
- 510 Pages
Global
From €2659EUR$3,000USD£2,289GBP
- Drug Pipelines
- May 2022
- 400 Pages
Global
From €2659EUR$3,000USD£2,289GBP
- Report
- May 2022
- 240 Pages
Global
From €2924EUR$3,300USD£2,518GBP
- Drug Pipelines
- March 2022
- 900 Pages
Global
From €7976EUR$9,000USD£6,868GBP
- Report
- November 2021
- 222 Pages
Global
From €2659EUR$3,000USD£2,289GBP
- Report
- August 2021
- 105 Pages
Global
From €1772EUR$2,000USD£1,526GBP
- Report
- July 2021
- 60 Pages
Global
From €1772EUR$2,000USD£1,526GBP
- Report
- March 2021
- 240 Pages
United States
From €2659EUR$3,000USD£2,289GBP
- Report
- April 2018
- 470 Pages
Global
From €2659EUR$3,000USD£2,289GBP
- Report
- October 2021
- 82 Pages
Global
From €3412EUR$3,850USD£2,938GBP
- Report
- October 2021
- 68 Pages
Global
From €3412EUR$3,850USD£2,938GBP
- Report
- October 2021
- 110 Pages
Global
From €6070EUR$6,850USD£5,228GBP
- Report
- August 2024
- 660 Pages
Brazil
From €2924EUR$3,300USD£2,518GBP
- Report
- July 2024
- 500 Pages
Turkey
From €2924EUR$3,300USD£2,518GBP
- Report
- May 2024
- 420 Pages
Global
From €2659EUR$3,000USD£2,289GBP
- Report
- February 2024
- 50 Pages
Global
From €2127EUR$2,400USD£1,832GBP
- Report
- February 2024
- 50 Pages
Global
From €2127EUR$2,400USD£1,832GBP
- Report
- February 2022
- 360 Pages
United States
From €3190EUR$3,600USD£2,747GBP
- Report
- December 2021
- 120 Pages
Global
From €2924EUR$3,300USD£2,518GBP

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy.
The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more